Contains articles from Dante and our partners discussing the latest research, publications, and updates about genome sequencing.
Genomic Biopharma Inc logo
About Us

Dante Genomics creates separate drug discovery and development company Genomic Biopharma Inc.

Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company’s co-founder and CEO Andrea Riposati presented as an opening speaker on Tuesday, September 27, 2022 at the 77th United Nations General Assembly (UNGA) Science Summit, where he unveiled the Company’s Digital Health Population Genomics Program in Europe, including living labs, which are groundbreaking pilot studies with fast impact on a country’s society and digital health.

Read More ➝